🎧 MSRA Deep Dive: Polyarteritis Nodosa (PAN)
Welcome back to the MSRA Revision Podcast! Today we’re exploring Polyarteritis Nodosa, a rare but clinically significant vasculitis affecting medium-sized arteries 🩸. This condition can affect multiple organs — and it’s essential for exam prep!
Whether you're revising for exams or reviewing real-world cases, this is your essential, high-yield guide 💥.
🧠 What is PAN?
PAN is a systemic necrotising vasculitis that affects medium-sized arteries, causing damage to vessel walls and ischemia.
Key facts:
🔍 Causes & Risk Factors
⚠️ Cause unknown
🔗 Linked with hepatitis B, hepatitis C, HIV, or autoimmune processes
👥 Most common in adults aged 40–60, more frequent in men
📉 Incidence falling due to hep B vaccination
🧬 Rare genetic forms (DADA2 deficiency) also exist
⚠️ Symptoms & Red Flags
🌡️ Fever, fatigue, weight loss
🩺 Hypertension (esp. new-onset)
🦵 Mononeuritis multiplex (peripheral nerve damage)
🧑⚕️ Testicular pain
🖐️ Livedo reticularis
🩸 Hematuria without glomerulonephritis
💥 Abdominal pain (mesenteric ischemia risk)
🧵 Skin: purpura, ulcers, subcutaneous nodules
🧠 CNS, cardiac, and renal involvement = higher mortality risk
🔬 Investigations
🧪 Bloods: ↑ ESR/CRP, hepatitis serology
❌ ANCA typically negative
🔬 Biopsy: necrotising arteritis (muscle, skin, nerves)
🖼️ Angiography: microaneurysms, stenosis, occlusions
🧠 Advanced: PET-CT for vascular inflammation
📋 ACR Criteria (Adults):
Need ≥3 of: weight loss, livedo reticularis, testicular pain, myalgias, neuropathy, HTN, renal impairment, Hep B, arteriogram changes, or biopsy findings
💊 Management Summary
🎯 Goal: control inflammation, preserve organs, minimise relapse
🌟 Mainstay:
🥄 Corticosteroids (prednisolone ± IV pulse)
💊 Cyclophosphamide for severe/systemic cases
🧪 Azathioprine/Methotrexate for maintenance
📌 Special cases:
Hep B PAN: antivirals + plasma exchange
Cutaneous PAN: NSAIDs ± low-dose steroids
DADA2 PAN: TNF inhibitors
Childhood PAN: IVIG, steroids, immunosuppressants if needed
📈 Prognosis
✔️ With treatment: 5-year survival >80%
❌ Untreated: survival <20%
🔁 Relapse rate <20%
🧫 Complications: renal failure, stroke, bowel infarction, aneurysm rupture, treatment-related infections or malignancy
📚 Useful MSRA Resources
📝 Revision Notes
https://www.passthemsra.com/topic/polyarteritis-nodosa-revision-notes/
🧠 Flashcards
https://www.passthemsra.com/topic/polyarteritis-nodosa-flashcards/
📖 Q&A Accordion Notes
https://www.passthemsra.com/topic/polyarteritis-nodosa-accordion-qa-notes/
🧪 Rapid Quiz
https://www.passthemsra.com/topic/polyarteritis-nodosa-rapid-quiz/
🧠 Full Quiz Access
https://www.passthemsra.com/quizzes/polyarteritis-nodosa/
🎓 MSK Course
https://www.passthemsra.com/courses/msk-for-the-msra/
🔖 Hashtags for Search & Engagement
#MSRA #MSRARevision #PolyarteritisNodosa #Vasculitis #MedicalRevision #MSRAFlashcards #MSRAQuiz #RheumatologyMSRA #PassTheMSRA